Report cover image

Point of Care (POC) HIV Testing Market Size, Share, and Outlook, H2-2025 Report- By Product (POC HIV testing equipment, POC HIV testing reagents), By End-User (Diagnostic labs, Hospitals and clinics, Others) and Companies, 2021-2032

Publisher VPA Research
Published Sep 01, 2025
Length 184 Pages
SKU # VPA20330370

Description

Point of Care (POC) HIV Testing Market Outlook
The global Point of Care (POC) HIV Testing Market Size is valued at $1.9 Billion in 2025 and is forecast to reach $2.4 Billion in 2032 at a CAGR of 3.5%.
The Point of Care (POC) HIV Testing Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Point of Care (POC) HIV Testing Market segments across 22 countries from 2021 to 2032. Key segments covered include By Product (POC HIV testing equipment, POC HIV testing reagents), By End-User (Diagnostic labs, Hospitals and clinics, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.

Point of Care (POC) HIV Testing Market Insights, 2025
The POC HIV testing market has witnessed significant advancements toward increasing accessibility and reducing diagnostic turnaround times, crucial for early detection and treatment initiation. Recent innovations include rapid antibody and antigen combination tests with improved sensitivity and specificity, capable of delivering results within minutes. The integration of molecular diagnostics, such as nucleic acid amplification tests (NAAT), into portable formats is enhancing early infection detection during the window period. Smartphone-enabled POC devices are facilitating remote testing and telemedicine connectivity, expanding reach to underserved populations. Regulatory agencies are streamlining approval processes for high-performance POC assays, emphasizing ease of use and minimal training requirements. Initiatives targeting key populations and low-resource settings, supported by global health programs, are driving market expansion. The COVID-19 pandemic further accelerated adoption of decentralized testing infrastructure. Ongoing research aims to develop multiplexed platforms combining HIV with other sexually transmitted infections for comprehensive screening.

Five Trends Shaping the Global Point of Care (POC) HIV Testing Market in 2025 and Beyond
The global Point of Care (POC) HIV Testing Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.

What are the Biggest Opportunities for Growth in the Point of Care (POC) HIV Testing Industry?
The Point of Care (POC) HIV Testing Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Point of Care (POC) HIV Testing Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.

Point of Care (POC) HIV Testing Market Segment Insights
The Point of Care (POC) HIV Testing Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Product (POC HIV testing equipment, POC HIV testing reagents), By End-User (Diagnostic labs, Hospitals and clinics, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.

Point of Care (POC) HIV Testing Industry Value Chain
The chapter identifies potential companies and their operations across the global Point of Care (POC) HIV Testing Industry ecosystem. It assists decision-makers in evaluating global Point of Care (POC) HIV Testing Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.

Scenario Analysis and Forecasts
Strategic planning in the Point of Care (POC) HIV Testing Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.

Asia Pacific Point of Care (POC) HIV Testing Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Point of Care (POC) HIV Testing Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.

United States Point of Care (POC) HIV Testing Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Point of Care (POC) HIV Testing Market.

Europe Point of Care (POC) HIV Testing Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Point of Care (POC) HIV Testing Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Point of Care (POC) HIV Testing Industry competitiveness. The report analyses the key Point of Care (POC) HIV Testing Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.

Latin American Point of Care (POC) HIV Testing Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Point of Care (POC) HIV Testing Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.

Middle East and Africa Point of Care (POC) HIV Testing Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Point of Care (POC) HIV Testing Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.

Competitive Landscape – How Point of Care (POC) HIV Testing Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Point of Care (POC) HIV Testing Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes AltraTech Ltd, Becton, Dickinson and Company, binx health Inc, bioMerieux SA, Cochrane, Community Pharmacy England, CVS Health Corp, Danaher Corp, DrSafeHands, F. Hoffmann La Roche Ltd, Island Health, J. Mitra and Co. Pvt. Ltd, MH Sub I LLC, Orchard Healthcare Pvt. Ltd. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.

Point of Care (POC) HIV Testing Market Scope
Leading Segments
By Product
POC HIV testing equipment
POC HIV testing reagents
By End-User
Diagnostic labs
Hospitals and clinics
Others

Leading Companies
AltraTech Ltd
Becton, Dickinson and Company
binx health Inc
bioMerieux SA
Cochrane
Community Pharmacy England
CVS Health Corp
Danaher Corp
DrSafeHands
F. Hoffmann La Roche Ltd
Island Health
J. Mitra and Co. Pvt. Ltd
MH Sub I LLC
Orchard Healthcare Pvt. Ltd

Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Reasons to Buy the Report
  • Make informed decisions with 12-year forecasts across 22 countries and multiple market segments.
  • Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry.
  • Gain insights into the competitive landscape, including company profiles, financials, and strategic moves.
  • Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations.
  • Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade.
  • Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions.
  • Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
  • Table of Contents

    184 Pages
    1. Table of Contents
    List of Figures and Tables
    2. Executive Summary
    2.1 Key Highlights
    2.1.1 Point of Care (POC) HIV Testing Market Size Outlook, 2018-2024 and 2025-2032
    2.1.2 Largest Point of Care (POC) HIV Testing Market Types and Applications
    2.1.3 Fastest Growing Segments
    2.1.4 Potential Markets
    2.1.5 Market Concentration
    2.2 Market Scope and Segmentation
    2.2.1 Market Scope- Segments
    2.2.2 Market Scope- Countries
    2.2.3 Macroeconomic and Demographic Outlook
    2.2.4 Abbreviations
    2.2.5 Units and Currency Conversions
    3. Research Methodology
    3.1 Primary Research Surveys
    3.2 Secondary Data Sources
    3.3 Data Triangulation
    3.4 Forecast Methodology
    3.5 Assumptions and Limitations
    4. Introduction to Global Point of Care (POC) HIV Testing Market in 2025
    4.1 Industry Panorama
    4.2 Leading Companies Profiled in the Study
    4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
    4.4 Market Dynamics
    4.4.1 Market Dynamics- Trends and Drivers
    4.4.2 Market Dynamics- Opportunities and Challenges
    4.5 Regional Analysis
    4.6 Porter’s Five Force Analysis
    4.6.1 Intensity of Competitive Rivalry
    4.6.2 Threat of New Entrants
    4.6.3 Threat of Substitutes
    4.6.4 Bargaining Power of Buyers
    4.6.5 Bargaining Power of Suppliers
    4.7 Point of Care (POC) HIV Testing Market Industry Value Chain Analysis
    4.7.1 Stage of Value Chain
    4.7.2 Key Activities of Companies
    4.7.3 Companies Included in Each Stage
    4.7.4 Key Insights
    5. Point of Care (POC) HIV Testing Market Outlook to 2032
    5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
    5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
    5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
    By Product
    POC HIV testing equipment
    POC HIV testing reagents
    By End-User
    Diagnostic labs
    Hospitals and clinics
    Others
    6. Global Point of Care (POC) HIV Testing Market Outlook across Growth Scenarios
    6.1 Low Growth Scenario
    6.2 Base/Reference Case
    6.3 High Growth Scenario
    6. North America Point of Care (POC) HIV Testing Market Size Outlook
    6.1 Key Market Statistics, 2024
    6.2 North America Point of Care (POC) HIV Testing Market Trends and Growth Opportunities
    6.2.1 North America Point of Care (POC) HIV Testing Market Outlook by Type
    6.2.2 North America Point of Care (POC) HIV Testing Market Outlook by Application
    6.3 North America Point of Care (POC) HIV Testing Market Outlook by Country
    6.3.1 The US Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    6.3.2 Canada Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    6.3.3 Mexico Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    7. Europe Point of Care (POC) HIV Testing Market Size Outlook
    7.1 Key Market Statistics, 2024
    7.2 Europe Point of Care (POC) HIV Testing Market Trends and Growth Opportunities
    7.2.1 Europe Point of Care (POC) HIV Testing Market Outlook by Type
    7.2.2 Europe Point of Care (POC) HIV Testing Market Outlook by Application
    7.3 Europe Point of Care (POC) HIV Testing Market Outlook by Country
    7.3.2 Germany Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    7.3.3 France Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    7.3.4 The UK Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    7.3.5 Spain Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    7.3.6 Italy Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    7.3.7 Russia Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    7.3.8 Rest of Europe Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    8. Asia Pacific Point of Care (POC) HIV Testing Market Size Outlook
    8.1 Key Market Statistics, 2024
    8.2 Asia Pacific Point of Care (POC) HIV Testing Market Trends and Growth Opportunities
    8.2.1 Asia Pacific Point of Care (POC) HIV Testing Market Outlook by Type
    8.2.2 Asia Pacific Point of Care (POC) HIV Testing Market Outlook by Application
    8.3 Asia Pacific Point of Care (POC) HIV Testing Market Outlook by Country
    8.3.1 China Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    8.3.2 India Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    8.3.3 Japan Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    8.3.4 South Korea Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    8.3.5 Australia Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    8.3.6 South East Asia Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    8.3.7 Rest of Asia Pacific Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    9. South America Point of Care (POC) HIV Testing Market Size Outlook
    9.1 Key Market Statistics, 2024
    9.2 South America Point of Care (POC) HIV Testing Market Trends and Growth Opportunities
    9.2.1 South America Point of Care (POC) HIV Testing Market Outlook by Type
    9.2.2 South America Point of Care (POC) HIV Testing Market Outlook by Application
    9.3 South America Point of Care (POC) HIV Testing Market Outlook by Country
    9.3.1 Brazil Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    9.3.2 Argentina Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    9.3.3 Rest of South and Central America Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    10. Middle East and Africa Point of Care (POC) HIV Testing Market Size Outlook
    10.1 Key Market Statistics, 2024
    10.2 Middle East and Africa Point of Care (POC) HIV Testing Market Trends and Growth Opportunities
    10.2.1 Middle East and Africa Point of Care (POC) HIV Testing Market Outlook by Type
    10.2.2 Middle East and Africa Point of Care (POC) HIV Testing Market Outlook by Application
    10.3 Middle East and Africa Point of Care (POC) HIV Testing Market Outlook by Country
    10.3.1 Saudi Arabia Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    10.3.2 The UAE Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    10.3.3 Rest of Middle East Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    10.3.4 South Africa Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    10.3.5 Egypt Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    10.3.6 Rest of Africa Point of Care (POC) HIV Testing Market Outlook, 2021- 2032
    11. Company Profiles
    11.1 Leading 10 Companies
    AltraTech Ltd
    Becton, Dickinson and Company
    binx health Inc
    bioMerieux SA
    Cochrane
    Community Pharmacy England
    CVS Health Corp
    Danaher Corp
    DrSafeHands
    F. Hoffmann La Roche Ltd
    Island Health
    J. Mitra and Co. Pvt. Ltd
    MH Sub I LLC
    Orchard Healthcare Pvt. Ltd
    11.2 Overview
    11.3 Products and Services
    11.4 SWOT Profile
    12. Appendix
    12.1 Subscription Options
    12.2 Customization Options
    12.3 Publisher Details
    How Do Licenses Work?
    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.